Search

Displaying results 1831 - 1840 of 10000 in total
  1. Drug

    Mupirocin

    go.drugbank.com/drugs/DB00410
    ApprovedInvestigationalVet approved

    Mupirocin, formerly termed pseudomonic acid A, is a novel antibacterial agent with a unique chemical structure and mode of action apart from other antibiotic agents. Produced by fermentation using the organism Pseudomonas fluorescens, mu...

    Synonyms: 9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3- [(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl] oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoic acidProducts: InfectoPyoderm 20 mg/g Salbe, Mupirocin InfectoPharm 20 mg/g Nasensalbe
  2. Drug

    CXL-1020

    go.drugbank.com/drugs/DB15326
    Investigational

    CXL-1020 is under investigation in clinical trial NCT01092325 (Safety and Hemodynamic Effects and Pharmacokinetics of CXL-1020 in Patients With Stable Heart Failure).

  3. Drug

    LAX-101

    go.drugbank.com/drugs/DB05301
    Investigational

    LAX-101 treats hungtington’s disease, not just the symptoms but the disease itself. The active molecule in LAX-101 is Eicosapentaenoic Acid (EPA). All molecules of EPA are identical. … The molecules of EPA found in LAX-101 are identical to the molecules of EPA found in fish oil food supplements.

  4. Drug

    Dexrabeprazole

    go.drugbank.com/drugs/DB13762
    Investigational

    Mixtures: DEXRIDON MR 30/10 MG KAPSÜL ,30 KAPSÜLCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2C19 Substrates
  5. Drug

    BAY-876

    go.drugbank.com/drugs/DB16758
    Experimental

    Synonyms: BAY 876
  6. Drug

    ORP-101

    go.drugbank.com/drugs/DB16072
    Investigational

    ORP-101 is under investigation in clinical trial NCT04129619 (A Comparison of the Effects of ORP-101 Versus Placebo in Adult Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D)).

  7. Drug

    TZ-101

    go.drugbank.com/drugs/DB18690
    Experimental

    TZ-101 composes of [GDP-L-fucose] and fucosyltransferase VI

  8. Drug

    CAM-101

    go.drugbank.com/drugs/DB18414
    Investigational

    CAM-101 is an allogeneic human platelet lysate product depleted of fibrinogen.

  9. Drug

    PX-102

    go.drugbank.com/drugs/DB15416
    Investigational

    PX-102 is under investigation in clinical trial NCT01998672 (Multiple Ascending Oral Dose Phase I Study With Px-102).

  10. Drug

    RAP-103

    go.drugbank.com/drugs/DB28444
    Experimental

    RAP-103 is a multi-chemokine receptor antagonist which is orally active.[A274606, A274611]